However, in the present study, we have successfully obtained simultaneous manipulation of both Kras and p53 expression in vivo as attested by the development of soft tissue sarcoma tumors and urothelial hyperplasia (Figure 7E). The gene discussed is KRAS; the disease is urothelial hyperplasia.